» Articles » PMID: 29072164

Effects of a Lipid Emulsion Containing Fish Oil on Polyunsaturated Fatty Acid Profiles, Growth and Morbidities in Extremely Premature Infants: A Randomized Controlled Trial

Abstract

Background & Aims: The purpose of the study was to compare the effects of the parenteral emulsion SMOFlipid, with 15% fish oil, with Clinoleic on retinopathy of prematurity (ROP) and other morbidities and growth, and to compare their impact on longitudinal serum levels of fatty acids. Retinopathy of prematurity, other morbidity and growth were correlated with each parenteral lipid supplement.

Methods: Ninety infants born at gestational age <28 weeks were randomized to treatment with SMOFlipid or Clinoleic. Two thirds (66%) of the infants received parenteral nutrition for up to 14 days birth (median 8, range 2-14 days), and additional 25% of the infants received for up to 28 days after birth (median 21, range 15-28 days). Cord blood samples and then venous blood samples were obtained at ages 1, 7, 14, and 28 days and at postmenstrual age (PMA) 32, 36, and 40 weeks. Breastmilk was collected at postnatal day 7, and at PMA 32 and 40 weeks. Serum phospholipid and breastmilk total fatty acids were analyzed by gas chromatography-mass spectrometry. Treatment groups were compared with regard to ROP, bronchopulmonary dysplasia, necrotizing enterocolitis, patent ductus arteriosus sepsis and growth between birth and 36 weeks.

Results: Infants on SMOFlipid had higher fractions of omega-3 LCPUFA eicosapentaenoic acid (EPA) and slightly higher omega-3 LCPUFA docosahexaenoic acid (DHA) fraction and a decreased arachidonic acid (AA) to DHA ratio from one week after birth up to 32 postmenstrual weeks compared to infants on Clinoleic. Treatment groups did not differ in morbidities or growth.

Conclusion: Supplementation with SMOFlipid containing 15% fish oil during parenteral nutrition increased EPA substantially, DHA marginally, reduced AA and decreased AA to DHA ratio. It did not reduce morbidity or affect growth. Since extremely preterm infants accumulate a large deficit of DHA and AA, studies on more prolonged or different levels of DHA and AA supplementation are warranted.

Citing Articles

Essential fatty acid deficiency in parenteral nutrition: Historical perspective and modern solutions, a narrative review.

Wolff J, Cober M, Huff K Nutr Clin Pract. 2025; 40(2):350-367.

PMID: 39961748 PMC: 11879921. DOI: 10.1002/ncp.11278.


Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial.

Lundgren P, Pivodic A, Nilsson A, Hellgren G, Danielsson H, Wackernagel D Pediatr Res. 2024; .

PMID: 39702768 DOI: 10.1038/s41390-024-03775-3.


Cytokine and growth factor correlation networks associated with morbidities in extremely preterm infants.

Golubinskaya V, Nilsson H, Rydbeck H, Hellstrom W, Hellgren G, Hellstrom A BMC Pediatr. 2024; 24(1):723.

PMID: 39529072 PMC: 11555815. DOI: 10.1186/s12887-024-05203-1.


Postnatal Dysregulation of Androgens in Extremely Preterm Male Infants.

Nilsson A, Sjobom U, Landin A, Andersson M, Ryberg H, Pivodic A J Endocr Soc. 2024; 8(12):bvae179.

PMID: 39512921 PMC: 11542631. DOI: 10.1210/jendso/bvae179.


Long-chain polyunsaturated fatty acids supplementation and sepsis: a systematic review and meta-analysis.

Witte Castro A, Couce M, de Lamas C, Lopez-Gimenez M, Jimenez Varas M, Zozaya C Pediatr Res. 2024; .

PMID: 39300278 DOI: 10.1038/s41390-024-03579-5.


References
1.
Collins C, Sullivan T, McPhee A, Stark M, Makrides M, Gibson R . A dose response randomised controlled trial of docosahexaenoic acid (DHA) in preterm infants. Prostaglandins Leukot Essent Fatty Acids. 2015; 99:1-6. DOI: 10.1016/j.plefa.2015.04.003. View

2.
Hsieh A, Anthony J, Diersen-Schade D, Rumsey S, Lawrence P, Li C . The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr Res. 2007; 61(5 Pt 1):537-45. DOI: 10.1203/pdr.0b013e318045bec9. View

3.
Lapillonne A, Groh-Wargo S, Gonzalez C, Uauy R . Lipid needs of preterm infants: updated recommendations. J Pediatr. 2013; 162(3 Suppl):S37-47. DOI: 10.1016/j.jpeds.2012.11.052. View

4.
Baack M, Puumala S, Messier S, Pritchett D, Harris W . Daily Enteral DHA Supplementation Alleviates Deficiency in Premature Infants. Lipids. 2016; 51(4):423-33. PMC: 4818658. DOI: 10.1007/s11745-016-4130-4. View

5.
Munzenmaier D, Harder D . Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release. Am J Physiol Heart Circ Physiol. 2000; 278(4):H1163-7. DOI: 10.1152/ajpheart.2000.278.4.H1163. View